AVROBIO
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Dise Gaucher Disease, Type 3 | Phase 2 / Phase 3 | 2023-10-01 |
| Terminated | A Long-Term Follow-up Study of Subjects With Gaucher Disease Who Previously Received AVR-RD-02 Type 1 Gaucher Disease | — | 2021-07-06 |
| Terminated | Lentiviral Vector Gene Therapy - The Guard1 Trial of AVR-RD-02 for Subjects With Type 1 Gaucher Disease Gaucher Disease | Phase 1 / Phase 2 | 2019-05-30 |
| Terminated | Long-Term Follow-up Study of Subjects With Fabry Disease Who Received Lentiviral Gene Therapy in Study AVRO-RD Fabry Disease | — | 2019-05-08 |
| Terminated | Open Label, Study Of Efficacy and Safety Of AVR-RD-01 for Treatment-Naive Subjects With Classic Fabry Disease Fabry Disease | Phase 1 / Phase 2 | 2018-02-21 |